SCHEMBL28636148

SCHEMBL28636148

CCC(C)(C)NC(=O)OC[C@H](C)CCC=C(C)C

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.47
ALDH1A1 P00352 2/20 0.39
USP2 O75604 1/20 0.35
GGPS1 O95749 2/20 0.34
FDPS P14324 2/20 0.34
TSHR P16473 1/20 0.33
GLA P06280 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
EPHX2 P34913 1/20 0.32
HPGD P15428 1/20 0.32
NFE2L2 Q16236 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28925131 0.80 EPHX1 (0.34) TDP1HPGD
SCHEMBL28647883 0.72 ALOX15 (0.57) ALOX15ALDH1A1USP2GGPS1FDPS
SCHEMBL28647885 0.72 ALOX15 (0.57) ALOX15ALDH1A1USP2GGPS1FDPS
SCHEMBL6796980 0.70 ALOX15 (0.43) ALOX15ALDH1A1USP2GGPS1FDPS
SCHEMBL24492349 0.69 ALOX15 (0.43) ALOX15ALDH1A1USP2GGPS1FDPS
SCHEMBL24574354 0.69 ALOX15 (0.43) ALOX15ALDH1A1USP2GGPS1FDPS
SCHEMBL27243524 0.68 ALOX15 (0.47) ALOX15ALDH1A1USP2GGPS1FDPS
SCHEMBL27243515 0.68 ALOX15 (0.47) ALOX15ALDH1A1USP2GGPS1FDPS
SCHEMBL14472626 0.68 ALOX15 (0.51) ALOX15ALDH1A1USP2GGPS1FDPS
SCHEMBL29466607 0.68 MAPT (0.56) ALOX15ALDH1A1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115433207-A Macrocyclic heterocyclic compound as EGFR inhibitor and application thereof 南京圣和药业股份有限公司 2022-12-06 CN disclosed
CN-114656482-A Macrocyclic heterocyclic compound as EGFR inhibitor and application thereof 南京圣和药业股份有限公司 2022-06-24 CN disclosed
CN-113527335-A Macrocyclic compound as EGFR inhibitor and application thereof 南京圣和药业股份有限公司 2021-10-22 CN disclosed